跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,534 条关于
“BRAF inhibitor”
全部
20,534
临床试验
10,272
药物
4,082
机构
22
资讯
6,158
去年
BRAF Inhibitors Show Promise in Treatment of Relapsed/Refractory Hairy Cell Leukemia
前天
Japan Approves FoundationOne CDx as Companion Diagnostic for Tovorafenib in BRAF-Altered Glioma
2个月前
Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors
3个月前
Molecular Glue Degraders of HuR Suppress BRAF-Mutant Colorectal Cancer
5个月前
ASCO Expands TAPUR Study with First Antibody-Drug Conjugate and BRAF/MEK Inhibitor Combination
去年
Phase 3 Trial Shows Promise for Adjuvant BRAF/MEK Inhibitor Combination in High-Risk Melanoma
去年
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing to Advance Plixorafenib Clinical Trials
2年前
C4 Therapeutics' CFT1946 Shows Promise in BRAF V600 Mutant Solid Tumors
去年
FORE Biotherapeutics Reports Durable Clinical Benefit with Plixorafenib in BRAF-Altered Thyroid Cancers
上个月
Labcorp's PGDx elio Tissue Complete CDx Gains FDA Approval as Companion Diagnostic for BRAF-Mutant Advanced Melanoma
第 1 页,共 616 页
上一页
下一页